- BNF:
- 8.1.3
- Status:
- Red, Amber
- Decision Date:
- None
Comments
RED:1,2,3 If indicated for cancer
AMBER:1,2 2nd line where azathioprine CI or not tolerated and where indicated as per shared care - See shared care guideline for immunomodulating drugs
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
Amber Drug Classifications
- 1: Requiring specialist assessment to enable patient selection and initiation of treatment
- 2: Requiring short or medium term (e.g. 3-6 months) specialist monitoring of efficacy or until the patient is stable
search again